PHAXIAM Therapeutics S.A. Euronext Paris
Equities
PHXM
FR0011471135
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 EUR | 0.00% | +1.20% | -35.87% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
-0.06% | 22.02B | |
-17.84% | 20.9B | |
-9.21% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- PHXM Stock
- PHXM Stock
- News PHAXIAM Therapeutics S.A.
- ERYTECH Pharma S A : Says Early Trial of Lead Therapy Showed 'Encouraging Clinical Activity,' No Dose-Limiting Toxicity in First 6 Patients; Shares Rise 4% After Hours